EmeritusDX Acquires Sprint Diagnostics

EmeritusDX Acquires Freedom Pathology Partners

June 13, 2022

Healthcare Services

EmeritusDX, a cancer diagnostics and information company, has acquired Freedom Pathology Partners, a CAP- and CLIA-accredited laboratory based in Conshohocken, Pennsylvania. The acquisition expands EmeritusDX’s national presence and test menu—adding anatomic pathology, FISH, and molecular testing capabilities and strengthening relationships in dermatology, gastroenterology, and urology markets.

Exact Sciences Acquires Paradigm Diagnostics and Viomics

March 3, 2020

Healthcare Services

Exact Sciences Corp. has completed the acquisitions of Phoenix-based Paradigm Diagnostics, Inc. and Viomics, Inc., adding a late-stage therapy selection genomic profiling test, a scalable clinical lab, and sequencing/biomarker discovery capabilities to its precision oncology portfolio. The deals (financial terms largely undisclosed in the company release) bring Paradigm and Viomics into Exact Sciences’ research and commercial platform to accelerate tissue- and blood-based advanced cancer diagnostics.

Quest Diagnostics Acquires Haystack Oncology

April 27, 2023

Healthcare Services

Quest Diagnostics has agreed to acquire Haystack Oncology in an all-cash transaction valued at $300 million at closing plus up to $150 million in potential milestones. The acquisition adds Haystack's sensitive ctDNA-based minimal residual disease (MRD) liquid biopsy technology to Quest's oncology, genomics and pathology capabilities to expand clinical lab services for MRD testing beginning in 2024.

Quest Diagnostics Acquires Pack Health

January 18, 2022

Healthcare Services

Quest Diagnostics has entered into a definitive agreement to acquire Pack Health in an all-cash transaction. The acquisition brings Pack Health's patient-engagement platform and certified health coaches into Quest's Extended Care services to strengthen value-based care and connect diagnostic insights to action.

Invitae Acquires ArcherDX to Build a Precision Oncology Genetics Platform

June 22, 2020

Healthcare Services

Invitae has entered into a definitive agreement to acquire ArcherDX in a cash-and-stock transaction valued at approximately $1.4 billion, combining Invitae's diagnostic and hereditary testing capabilities with ArcherDX's somatic genomics, liquid biopsy and bioinformatics platform. The deal is intended to integrate germline and somatic testing, expand precision oncology offerings, and accelerate adoption of comprehensive cancer genetics across clinical and biopharma customers worldwide.

TridentCare Acquires DispatchHealth's Imaging Business Unit

January 20, 2026

Healthcare Services

TridentCare has acquired DispatchHealth's imaging business unit, effective January 20, 2026. The unit—operating portable X-ray and ultrasound services across 16 states—will be integrated into TridentCare's national portable diagnostics platform to expand capability, improve scheduling and response times, and broaden geographic coverage.